Members

Amyl Therapeutics is developing a breakthrough platform of fusion proteins for the treatment of amyloid mediated diseases, including Alzheimer’s disease and Parkinson’s disease.

Aquilon Pharma aims to play a disruptive role in the next generation formulation technology for inhaled medication by improving the efficacy of inhaled drug.

BioLizard is a leading multinational bioinformatics, data analytics, and data management service and consulting company heading digital transformation in the life sciences industry.

BioSenic offers a unique treatment value by developing two innovative product lines: an arsenic trioxide-based treatment for autoimmune diseases and cell therapy products.

Bioxodes is a clinical stage company developing a first-in-class drug candidate, Ir-CPI, for the prevention of thrombosis and neuroinflammation in haemorrhagic stroke patients.

Cenexi is a global provider of contract development and manufacturing services.

CER Groupe is a Certified Research Center which provides services, analyses and products in medical, veterinarian, biotechnological, biomedical and agro-food fields.

Certech is a research & development partner and supplier of analytical and technological services for companies involved in activities related to (bio)chemistry.

DeuterOncology is a clinical-stage drug development company.

Hyloris is a specialty biopharma company identifying and unlocking hidden potential in existing medications for the benefit of patients, physicians, and the healthcare systems.

The Institute of Pathology and Genetics (IPG) is a laboratory specialized in medical diagnosis in anatomical pathology, molecular and cellular biology and clinical genetics.

Lonza Verviers is the European Service Center for Lonza Bioscience. It is both a production and distribution site for custom and research media.

Mestastop Solutions develops innovative solutions aimed at curbing the spread of cancer through the metastases responsible for 90% of deaths in patients with solid tumours.

is a private VC-backed company developing innovative therapies for the treatment of orphan CNS (central nervous system) diseases.